Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA Monitoring”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Not applicableUnknownNCT06103890
What this trial is testing

Dynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 100
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Large-scale testing (Phase 3)Active Not RecruitingNCT06939439
What this trial is testing

Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer

Who this might be right for
Gastric Cancer Stage III
The First Affiliated Hospital with Nanjing Medical University 416
Not applicableUnknownNCT05167604
What this trial is testing

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNext-Generation SequencingChemotherapy, Adjuvant+2 more
Tang-Du Hospital 150
Not applicableUnknownNCT03878537
What this trial is testing

Recurrence Monitoring in NSCLC Using Circulating Tumor DNA

Who this might be right for
Non Small Cell Lung Cancer
Scripps Translational Science Institute 50
Not applicableStudy completedNCT03465241
What this trial is testing

CtDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

Who this might be right for
NSCLC
Sun Yat-sen University 119
Not applicableActive Not RecruitingNCT04813627
What this trial is testing

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer Stage IIColorectal Cancer Stage III
BioNTech SE 2,200
Not applicableStudy completedNCT05066555
What this trial is testing

Circulating Tumor DNA Genotyping for Biological Monitoring of Patients Treated in the FIL-Rouge Clinical Trial

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 100
Not applicableUnknownNCT03651986
What this trial is testing

Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules

Who this might be right for
Pulmonary Nodules
AnchorDx Medical Co., Ltd. 10,560
Not applicableUnknownNCT05578625
What this trial is testing

CtDNA Methylation Sequencing for Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 66
Not applicableUnknownNCT03737539
What this trial is testing

Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA)

Who this might be right for
Colorectal CancerCirculating Tumor DNASurveillance+1 more
Fudan University 300
Not applicableNot Yet RecruitingNCT07152535
What this trial is testing

Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Peking University Cancer Hospital & Institute 255
Not applicableLooking for participantsNCT06479460
What this trial is testing

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

Who this might be right for
Breast CancerNeoadjuvantHER2-positive Breast Cancer+1 more
The First Affiliated Hospital with Nanjing Medical University 50
Not applicableStudy completedNCT03926260
What this trial is testing

Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Centre Hospitalier Departemental Vendee 100
Not applicableLooking for participantsNCT05778253
What this trial is testing

The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Who this might be right for
Lung Squamous Cell Carcinoma
Second Xiangya Hospital of Central South University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06970912
What this trial is testing

CtDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHigh-risk Breast CancerEarly-Stage Breast Cancer+3 more
Peking University People's Hospital 393
Not applicableLooking for participantsNCT05446545
What this trial is testing

Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 139
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07410611
What this trial is testing

CtDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy

Who this might be right for
Patients With Advanced Oligometastatic Non-small Cell Lung Cancer (NSCLC) Who Have Tested Positive for EGFR Mutations Confirmed by Histopathological Examination
Hebei Medical University Fourth Hospital 84
Not applicableNot Yet RecruitingNCT06287593
What this trial is testing

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Zhejiang University 300
Load More Results